Rohini Deshpande

Executive Director Process at Amgen, Inc.

Rohini Deshpande

Rohini Deshpande

Executive Director Process at Amgen, Inc.

Overview
Career Highlights

Amgen, Inc.

RelSci Relationships

1584

Contact Data
Trying to get in touch with Rohini Deshpande? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Rohini Deshpande likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman & Chief Executive Officer at Amgen, Inc.

Relationship likelihood: Strong

Secretary, Executive Vice President & General Counsel at Amgen, Inc.

Relationship likelihood: Strong

Former Executive Director-Finance at Amgen, Inc.

Relationship likelihood: Strong

Managing Director at Amgen Ventures LLC

Relationship likelihood: Strong

Chief Financial Officer at Amgen, Inc.

Relationship likelihood: Strong

Vice President & General Manager at Amgen Canada, Inc.

Relationship likelihood: Strong

Senior Vice President, Regional General Manager at Amgen, Inc.

Relationship likelihood: Strong

Executive Director & Head of Global Media Relations at Amgen, Inc.

Relationship likelihood: Strong

Executive Director, Corporate Development at Amgen, Inc.

Relationship likelihood: Strong

Senior Vice President, Manufacturing at Amgen, Inc.

Relationship likelihood: Strong

Paths to Rohini Deshpande
Potential Connections via
Relationship Science
You
Rohini Deshpande
Executive Director Process at Amgen, Inc.
Career History
Executive Director Process
Tenure Unconfirmed

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Other Affiliations

Rohini Deshpande is affiliated with Amgen, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Rohini Deshpande. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Rohini Deshpande's profile does not indicate a business or promotional relationship of any kind between RelSci and Rohini Deshpande.